tiprankstipranks
Trending News
More News >
Bodal Chemicals Limited (IN:BODALCHEM)
:BODALCHEM
India Market
Advertisement

Bodal Chemicals Limited (BODALCHEM) AI Stock Analysis

Compare
0 Followers

Top Page

IN:BODALCHEM

Bodal Chemicals Limited

(BODALCHEM)

Rating:52Neutral
Price Target:
₹72.00
▲(5.68% Upside)
Bodal Chemicals' overall stock score is primarily influenced by its financial performance and technical analysis. The company shows strong revenue growth and operational efficiency but faces challenges with profitability and free cash flow. Technical indicators point to potential weakness in the short term. Valuation metrics suggest the stock is overvalued, impacting the overall score negatively.

Bodal Chemicals Limited (BODALCHEM) vs. iShares MSCI India ETF (INDA)

Bodal Chemicals Limited Business Overview & Revenue Model

Company DescriptionBodal Chemicals Limited is a prominent chemical manufacturing company headquartered in India. It operates primarily in the chemical sector, focusing on the production of dye intermediates, dyestuffs, and basic chemicals. The company's comprehensive product range serves various industries, including textiles, leather, and paper.
How the Company Makes MoneyBodal Chemicals Limited generates revenue through the manufacturing and sale of a wide array of chemical products. The company's primary revenue streams include the production and distribution of dye intermediates, which are essential components in the textile industry for dye production. Additionally, Bodal Chemicals produces dyestuffs that are used directly by textile manufacturers. The company also offers basic chemicals utilized across multiple industries, thereby diversifying its revenue base. Strategic partnerships and collaborations with key industry players further enhance its market reach and profitability. Moreover, Bodal Chemicals leverages its extensive distribution network to supply products both domestically and internationally, contributing significantly to its earnings.

Bodal Chemicals Limited Financial Statement Overview

Summary
Bodal Chemicals demonstrates positive revenue growth and improved operational efficiencies with rising gross and EBIT margins. However, low net profit margin and negative free cash flow raise concerns about long-term sustainability. The balance sheet remains stable with strong equity and manageable debt levels. Improving net profit margins and cash flow generation will be crucial for enhancing financial health.
Income Statement
65
Positive
Bodal Chemicals has shown a mixed performance in its income statement. The company experienced a solid revenue growth rate of 25.12% from the previous year to 2025. However, its net profit margin is relatively low at 1.06%, reflecting challenges in converting revenues into profits. The gross profit margin improved significantly to 38.71% in 2025, indicating better cost management. The EBIT margin of 5.65% also shows a positive trend from prior years, suggesting operational efficiency improvements. Despite these positives, the low net profit margin remains a concern.
Balance Sheet
70
Positive
The balance sheet reveals a stable financial structure for Bodal Chemicals. The debt-to-equity ratio stands at 0.82, indicating a balanced approach to leveraging. The company's equity ratio of 46.94% suggests a strong equity base, although there is room for improvement. Return on equity (ROE) is low at 1.67%, highlighting inefficiencies in generating profits from equity. Overall, Bodal Chemicals maintains a stable financial position with manageable debt levels.
Cash Flow
55
Neutral
The cash flow statement shows Bodal Chemicals facing challenges in generating free cash flow, with a negative free cash flow in 2025. The operating cash flow to net income ratio is positive at 2.06, indicating that the company generates more cash than accounting profits, which is a positive sign. However, the negative free cash flow growth rate from 2024 to 2025 reflects ongoing capital expenditure pressures. The free cash flow to net income ratio is negative, pointing to potential liquidity issues if not addressed.
BreakdownMar 2025Mar 2024Mar 2022Mar 2023Mar 2021
Income Statement
Total Revenue17.45B13.95B20.27B15.74B12.21B
Gross Profit6.76B1.68B5.42B6.70B3.29B
EBITDA1.69B1.19B2.18B1.45B1.03B
Net Income185.02M64.69M1.04B380.33M419.82M
Balance Sheet
Total Assets23.53B22.88B21.22B21.21B17.48B
Cash, Cash Equivalents and Short-Term Investments360.60M462.50M93.95M225.87M119.14M
Total Debt9.11B8.47B5.76B6.98B3.47B
Total Liabilities12.48B12.06B10.70B10.43B7.68B
Stockholders Equity11.05B10.82B10.56B10.78B9.75B
Cash Flow
Free Cash Flow-83.36M-407.19M-1.73B-528.49M-1.91B
Operating Cash Flow381.14M2.04B-135.20M2.85B-130.17M
Investing Cash Flow-424.34M-2.62B-1.70B-3.10B-1.68B
Financing Cash Flow76.36M809.81M1.81B326.55M1.78B

Bodal Chemicals Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price68.13
Price Trends
50DMA
73.84
Negative
100DMA
70.85
Negative
200DMA
69.12
Positive
Market Momentum
MACD
-1.82
Positive
RSI
38.67
Neutral
STOCH
17.79
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BODALCHEM, the sentiment is Neutral. The current price of 68.13 is below the 20-day moving average (MA) of 73.51, below the 50-day MA of 73.84, and below the 200-day MA of 69.12, indicating a neutral trend. The MACD of -1.82 indicates Positive momentum. The RSI at 38.67 is Neutral, neither overbought nor oversold. The STOCH value of 17.79 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:BODALCHEM.

Bodal Chemicals Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (44)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
₹14.17B12.25
0.32%12.87%5.93%
67
Neutral
₹12.99B22.02
0.38%16.35%55.54%
64
Neutral
₹7.73B16.90
0.86%25.56%92.57%
61
Neutral
₹29.80B15.84
-12.76%-17.97%
54
Neutral
₹11.02B118.52
0.88%-19.46%-80.73%
52
Neutral
₹8.73B29.89
0.17%19.75%844.66%
44
Neutral
C$923.76M-8.68-0.23%2.69%24.53%-41.45%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:BODALCHEM
Bodal Chemicals Limited
66.34
-7.99
-10.75%
IN:AGARIND
Agarwal Industrial Corporation Limited
947.55
-268.20
-22.06%
IN:BHAGERIA
Bhageria Industries Ltd.
174.10
4.31
2.54%
IN:FAIRCHEMOR
Fairchem Organics Ltd
845.70
-458.52
-35.16%
IN:KIRIINDUS
Kiri Industries Limited
530.65
198.90
59.95%
IN:SHREEPUSHK
Shree Pushkar Chemicals & Fertilisers Ltd.
339.05
94.59
38.69%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 02, 2025